IOVA - Iovance Biotherapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development71,61526,94115,4703,849
Selling General and Administrative21,26217,19812,3908,192
Non Recurring----
Total Operating Expenses92,87744,13927,86012,041
Operating Income or Loss-92,877-44,139-27,860-12,041
Income from Continuing Operations
Total Other Income/Expenses Net813-8,7552006
Earnings Before Interest and Taxes-92,877-44,139-27,860-12,041
Interest Expense----
Income Before Tax-92,064-52,894-27,660-12,035
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-92,064-52,894-27,660-12,035
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-92,064-52,894-27,660-12,035
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-92,064-102,348-27,660-12,035